Dataset of GWAS-identified variants underlying venous thromboembolism susceptibility and linkage to cancer aggressiveness

scientific article published on 09 March 2020

Dataset of GWAS-identified variants underlying venous thromboembolism susceptibility and linkage to cancer aggressiveness is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.DIB.2020.105399
P932PMC publication ID7114903
P698PubMed publication ID32258274

P50authorRui MedeirosQ38327360
P2093author name stringDeolinda Pereira
Ricardo Pinto
Joana Assis
Valéria Tavares
P2860cites workAnti-cancer effects of dopamine in human glioma: involvement of mitochondrial apoptotic and anti-inflammatory pathwaysQ47129910
NB-3/Notch1 pathway via Deltex1 promotes neural progenitor cell differentiation into oligodendrocytesQ47769650
Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach.Q51773327
TSPAN15 interacts with BTRC to promote oesophageal squamous cell carcinoma metastasis via activating NF-κB signaling.Q52590985
Interactions of established risk factors and a GWAS-based genetic risk score on the risk of venous thromboembolism.Q53080453
Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2 (FGF-2).Q53521001
Predicting venous thrombosis in women using a combination of genetic markers and clinical risk factorsQ57303396
Immunosuppression by micromolecular fibrinogen degradation products in cancerQ59074416
High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)Q72626710
Gene variants associated with deep vein thrombosisQ80893876
Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levelsQ81168187
Mitochondrial PIP3-binding protein FUNDC2 supports platelet survival via AKT signaling pathwayQ88768060
Glycosyltransferase Gene Expression Identifies a Poor Prognostic Colorectal Cancer Subtype Associated with Mismatch Repair Deficiency and Incomplete Glycan SynthesisQ88909697
Venous thromboembolism risk associated with ABO, F11 and FGG lociQ89565967
EphA3 contributes to tumor growth and angiogenesis in human gastric cancer cellsQ90683840
Venous thromboembolism GWAS reported genetic makeup and the hallmarks of cancer: Linkage to ovarian tumour behaviourQ91123681
EphA3 inhibits migration and invasion of esophageal cancer cells by activating the mesenchymal‑epithelial transition processQ93357294
The prognostic value of ABO blood group in cancer patientsQ26775411
The GATA2 transcriptional network is requisite for RAS oncogene-driven non-small cell lung cancerQ27851771
Coagulation, inflammation, and apoptosis: different roles for protein S and the protein S-C4b binding protein complex.Q34220804
The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinasesQ34319294
A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.Q34407258
Transforming growth factor-beta in T-cell biologyQ34572232
Genetic variation within the anticoagulant, procoagulant, fibrinolytic and innate immunity pathways as risk factors for venous thromboembolismQ35032797
Association of variation at the ABO locus with circulating levels of soluble intercellular adhesion molecule-1, soluble P-selectin, and soluble E-selectin: a meta-analysisQ35753072
Six Novel Loci Associated with Circulating VEGF Levels Identified by a Meta-analysis of Genome-Wide Association StudiesQ35934127
TGF beta signalling and its role in tumour pathogenesisQ36180627
Endothelial protein C receptor expressed by ovarian cancer cells as a possible biomarker of cancer onsetQ36640430
Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease.Q37711589
Platelets: linking hemostasis and cancerQ37808901
von Willebrand factor and cancer: a renewed interestQ38080207
The receptor tyrosine kinase Axl in cancer: biological functions and therapeutic implications.Q38104686
Prognostic DNA methylation markers for prostate cancer.Q38252624
Thrombomodulin reduces tumorigenic and metastatic potential of lung cancer cells by up-regulation of E-cadherin and down-regulation of N-cadherin expressionQ38768567
Snail1-dependent transcriptional repression of Cezanne2 in hepatocellular carcinoma.Q39136423
A shRNA functional screen reveals Nme6 and Nme7 are crucial for embryonic stem cell renewalQ39296177
Coagulation factors VIIa and Xa inhibit apoptosis and anoikisQ40599210
Activated protein C induces endothelial cell proliferation by mitogen-activated protein kinase activation in vitro and angiogenesis in vivo.Q44912816
Prothrombin A19911G polymorphism and the risk of venous thromboembolismQ45862527
P921main subjectvenous thromboembolismQ9397786
genome-wide association studyQ1098876
data setQ1172284
P304page(s)105399
P577publication date2020-03-09
P1433published inData in BriefQ23930059
P1476titleDataset of GWAS-identified variants underlying venous thromboembolism susceptibility and linkage to cancer aggressiveness
P478volume30